Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals

Antiviral Therapy

Volumn 14, Issue 8, 2009, Pages 1189-1193

  Taylor, Ninon ^a   Schmid, Ilse ^a   Egle, Alexander ^a   Greil, Richard ^a   Patsch, Wolfgang ^a   Oberkofler, Hannes ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; VIRUS LOAD;

HIV INFECTIONS; HIV-1; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; TAQ POLYMERASE; VIRAL LOAD;

EID: 73449125872     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1427     Document Type: Article

References (18)

1. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126:946-954.
2. Hammer SM, Eron JJ, Jr., Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA 2008; 300:555-570
3. Vernazza PL, Hirschel B. HIV transmission hunting - the chase for low risk events. Antivir Ther 2008; 13:641-642.
4. Peter JB, Sevall JS. Molecular-based methods for quantifying HIV viral load. AIDS Patient Care STDS 2004; 18:75-79.
5. Dezube BJ. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment. Expert Rev Anticancer Ther 2002; 2:193-200.
6. Korn K, Weissbrich B, Henke-Gendo C, et al. Single point mutations cause >100-fold underestimation of HIV-1 viral load with the COBAS TaqMan HIV-1 real-time PCR assay. J Clin Microbiol 2009; 47:1238-1240.
7. Gueudin M, Plantier JC, Lemee V, et al. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J Acquir Immune Defic Syndr 2007; 44:500-505.
8. Colson P, Solas C, Moreau J, Motte A, Henry M, Tamalet C. Impaired quantification of plasma HIV-1 RNA with a commercialized real-time PCR assay in a couple of HIV-1-infected individuals. J Clin Virol 2007; 39:226-229.
9. Damond F, Roquebert B, Benard A, et al. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays. J Clin Microbiol 2007; 45:3436-3438.
10. Drexler JF, Souza Luna LK, Pedroso C, et al. Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil. J Clin Microbiol 2007; 45:2061-2063.
11. de Oliveira T, Deforche K, Cassol S, Rambaut A, Vandamme A-M. REGA HIV-1 & 2 automated subtyping tool (version 2). (Accessed 27 April 2009.) Available from http://jose.med.kuleuven.be/genotypetool/html/indexhiv.html
12. Wirden M, Tubiana R, Marguet F, et al. Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes. J Clin Microbiol 2009; 47:1543-1545.
13. Sloma CR, Germer JJ, Gerads TM, Mandrekar JN, Mitchell PS, Yao JD. Comparison of the Abbott realtime human immunodeficiency virus type 1 (HIV-1) assay to the Cobas AmpliPrep/Cobas TaqMan HIV-1 test: workflow, reliability, and direct costs. J Clin Microbiol 2009; 47:889-895.
14. Huang J, Yang CM, Wang LN, Meng S, Deng W, Li JM. A novel real-time multiplex reverse transcriptase-polymerase chain reaction for the detection of HIV-1 RNA by using dual-specific armored RNA as internal control. Intervirology 2008; 51:42-49.
15. Lima V, Harrigan R, Montaner JS. Increased reporting of detectable plasma HIV-1 RNA levels at the critical threshold of 50 copies per milliliter with the Taqman assay in comparison to the Amplicor assay. J Acquir Immune Defic Syndr 2009; 51:3-6.
16. Gatanaga H, Tsukada K, Honda H, et al. Detection of HIV type 1 load by the Roche Cobas TaqMan assay in patients with viral loads previously undetectable by the Roche Cobas Amplicor Monitor. Clin Infect Dis 2009; 48:260-262.
17. Manavi K. The significance of low-level plasma HIV viral load on COBAS TaqMan HIV-1 assays for patients with undetectable plasma viral load on COBAS Amplicor monitor version 1.5. HIV Clin Trials 2008; 9:283-286.
18. Smit E, Bhattacharya S, Osman H, Taylor S. Increased frequency of HIV-1 viral load blip rate observed after switching from Roche Cobas Amplicor to Cobas Taqman assay. J Acquir Immune Defic Syndr 2009; 51:364-365.